ARCHIVES

Review Group Report: NCI Role In Drug Development Seen As Information Provider

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

November 28, 2014

Another HHS Recommendation: Screen 50 And Older For Colorectal Cancer;

March 15, 2002

NCI Continues Making Improvements In Contract Management

May 22, 1981

Nelson Elected ACCC Veep

February 13, 1976

Grants Awarded To Combat Tobacco In Developing Countries

October 4, 2002

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003